KCG Holdings Inc. lowered its position in shares of Maximus, Inc. (NYSE:MMS) by 37.3% during the first quarter, according to its most recent filing with the SEC. The fund owned 4,723 shares of the health services provider’s stock after selling 2,807 shares during the period. KCG Holdings Inc.’s holdings in Maximus were worth $294,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in the stock. World Asset Management Inc raised its position in Maximus by 0.8% in the first quarter. World Asset Management Inc now owns 3,976 shares of the health services provider’s stock worth $247,000 after buying an additional 30 shares in the last quarter. Neuburgh Advisers LLC raised its position in Maximus by 1.9% in the first quarter. Neuburgh Advisers LLC now owns 1,696 shares of the health services provider’s stock worth $105,000 after buying an additional 32 shares in the last quarter. Glen Harbor Capital Management LLC raised its position in Maximus by 1.9% in the first quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock worth $145,000 after buying an additional 44 shares in the last quarter. Elkfork Partners LLC raised its position in Maximus by 1.9% in the first quarter. Elkfork Partners LLC now owns 2,968 shares of the health services provider’s stock worth $185,000 after buying an additional 56 shares in the last quarter. Finally, Meadow Creek Investment Management LLC raised its position in Maximus by 1.9% in the first quarter. Meadow Creek Investment Management LLC now owns 3,604 shares of the health services provider’s stock worth $224,000 after buying an additional 68 shares in the last quarter. 97.20% of the stock is currently owned by institutional investors.
Maximus, Inc. (MMS) traded down 0.08% during trading on Friday, reaching $59.30. 301,822 shares of the company’s stock traded hands. The firm’s 50 day moving average is $60.78 and its 200 day moving average is $61.00. The company has a market cap of $3.85 billion, a P/E ratio of 19.01 and a beta of 1.39. Maximus, Inc. has a 12 month low of $43.69 and a 12 month high of $64.97.
Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The business had revenue of $600.40 million for the quarter, compared to analyst estimates of $614.12 million. During the same period in the prior year, the business posted $0.79 earnings per share. Maximus’s revenue was down 2.7% compared to the same quarter last year. Analysts anticipate that Maximus, Inc. will post $3.12 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, August 31st. Shareholders of record on Tuesday, August 15th will be paid a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 0.30%. The ex-dividend date of this dividend is Friday, August 11th. Maximus’s payout ratio is presently 5.73%.
TRADEMARK VIOLATION NOTICE: “KCG Holdings Inc. Sells 2,807 Shares of Maximus, Inc. (NYSE:MMS)” was posted by BNB Daily and is the property of of BNB Daily. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The correct version of this piece can be read at https://www.baseball-news-blog.com/2017/08/19/kcg-holdings-inc-cuts-stake-in-maximus-inc-nysemms-updated-updated-updated.html.
A number of research analysts recently commented on MMS shares. Canaccord Genuity lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 price objective on the stock. in a research note on Tuesday, July 4th. Jefferies Group LLC lowered shares of Maximus from a “buy” rating to a “hold” rating and lifted their price target for the stock from $63.00 to $64.00 in a research report on Friday, May 5th. Maxim Group lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $66.00 price target on the stock. in a research report on Thursday, May 4th. They noted that the move was a valuation call. ValuEngine lowered shares of Maximus from a “buy” rating to a “hold” rating in a research report on Tuesday, May 16th. Finally, KeyCorp restated a “sector weight” rating on shares of Maximus in a research report on Thursday, May 25th. One equities research analyst has rated the stock with a sell rating and eight have assigned a hold rating to the stock. Maximus presently has a consensus rating of “Hold” and a consensus price target of $62.17.
In other news, President Bruce Caswell sold 8,000 shares of the stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $62.76, for a total transaction of $502,080.00. Following the completion of the sale, the president now owns 35,904 shares of the company’s stock, valued at $2,253,335.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Richard A. Montoni sold 29,203 shares of the firm’s stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $60.38, for a total transaction of $1,763,277.14. Following the completion of the transaction, the chief executive officer now directly owns 549,215 shares of the company’s stock, valued at approximately $33,161,601.70. The disclosure for this sale can be found here. Insiders sold 154,342 shares of company stock valued at $9,516,217 in the last ninety days. Insiders own 3.10% of the company’s stock.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.